Form 4 holding
President and CEO, Director
Phathom Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 373,315
- Estimated value
- $4,785,898
- Report date
- 10 Feb 2026
- Price
- $12.82
- Ownership
- Direct
Steven L. Basta - President and CEO, Director at Phathom Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- PHAT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Steven L. Basta since 07 Jul 2025
Reported holdings for Steven L. Basta in Phathom Pharmaceuticals, Inc.
Form 4 holding
President and CEO, Director
Phathom Pharmaceuticals, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 221,156
- Estimated value
- Report date
- 02 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President and CEO, Director
Phathom Pharmaceuticals, Inc.
- Security class
- Performance Shares
- Shares / value
- 180,000
- Estimated value
- Report date
- 28 Nov 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President and CEO, Director
Phathom Pharmaceuticals, Inc.
- Security class
- No securities are beneficially owned.
- Shares / value
- 0
- Estimated value
- Report date
- 01 Apr 2025
- Price
- Ownership
- Direct
Transaction history for Steven L. Basta in Phathom Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.